Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,591,438 papers from all fields of science
Search
Sign In
Create Free Account
Histopathology
Known as:
Histopathologic
, Histopathologic Examination
, Histopathologic Study
The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Histology
Pathology processes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles.
M. Loebinger
,
P. Kyrtatos
,
+4 authors
S. Janes
Cancer Research
2009
Corpus ID: 1969009
The ability of mesenchymal stem cells (MSC) to specifically home to tumors has suggested their potential use as a delivery…
Expand
Review
2002
Review
2002
Surgical management of intraductal papillary mucinous tumor of the pancreas.
R. Doi
,
K. Fujimoto
,
M. Wada
,
M. Imamura
Surgery
2002
Corpus ID: 21769805
BACKGROUND Intraductal papillary mucinous tumor (IPMT) is a type of pancreatic cystic neoplasm. IPMT consists of intraductal…
Expand
Highly Cited
1996
Highly Cited
1996
Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
U. Kunter
,
J. Buer
,
+8 authors
J. Atzpodien
Journal of the National Cancer Institute
1996
Corpus ID: 6701420
BACKGROUND The most widely accepted criteria for the evaluation of prognosis of malignant melanoma are histopathologic and…
Expand
Highly Cited
1995
Highly Cited
1995
Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice.
D M Bouley
,
S. Kanangat
,
W. Wire
,
B. T. Rouse
Journal of Immunology
1995
Corpus ID: 22500261
Herpetic stromal keratitis (HSK) has an immune-mediated pathogenesis that involves T cells that have a type 1 cytokine profile…
Expand
Highly Cited
1993
Highly Cited
1993
p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
R. Silvestrini
,
E. Benini
,
+5 authors
U. Veronesi
Journal of the National Cancer Institute
1993
Corpus ID: 12036846
BACKGROUND At present, most decisions concerning the use of adjuvant therapy in lymph node-negative breast cancer patients are…
Expand
Review
1992
Review
1992
Clinical implications of heterogeneity of tumor response to radiation therapy.
H. Suit
,
Steven J. Skates
,
A. Taghian
,
P. Okunieff
,
Jimmy T. Efird
Radiotherapy and Oncology
1992
Corpus ID: 4181631
Highly Cited
1981
Highly Cited
1981
Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration.
C. Litterst
Toxicology and Applied Pharmacology
1981
Corpus ID: 42687949
Review
1980
Review
1980
Experience with Gleason's histopathologic grading in prostatic cancer.
S. Kramer
,
J. Spahr
,
C. Brendler
,
J. Glenn
,
D. Paulson
Journal of Urology
1980
Corpus ID: 34319851
Highly Cited
1972
Highly Cited
1972
Clinical, radiologic, and histopathologic studies on pulmonary toxicity induced by treatment with bleomycin (NSC-125066).
M. Lena
,
A. Guzzon
,
S. Monfardini
,
G. Bonadonna
Cancer chemotherapy reports
1972
Corpus ID: 27424561
This study describes the clinical, roentgenologic, and histopathologic studies of pulmonary toxicity induced by treatment with…
Expand
Highly Cited
1953
Highly Cited
1953
ELECTRON MICROSCOPIC STUDIES OF THE ANTERIOR PITUITARY GLAND
J. F. Rinehart
,
M. Farquhar
Journal of Histochemistry and Cytochemistry
1953
Corpus ID: 17621262
Technical methods for preparation of thin sections suitable for electron microscopy, while exacting, have been developed to a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE